Profound Medical Announces Preliminary Unaudited Fourth

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
46
Profound Medical Announces Preliminary Unaudited Fourth Quarter 2018 Revenues

TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that combines real-time Magnetic Resonance (“MR”) imaging and ultrasound technology for the precise, incision-free ablation of diseased tissue, today announced preliminary unaudited revenues for the fourth quarter of 2018. Profound is providing this information due to the significant lag time between planned investment community meetings to be held in connection with, among other non-deal investor events, the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, and its expected reporting of final 2018 results in March 2019.

Profound anticipates total revenues for the fourth quarter of 2018 to be approximately $1.6 million, more than five-fold increase compared with approximately $0.3 million in the previous quarter. For the full year 2018, the Company anticipates total revenues to be approximately $2.5 million. These figures are preliminary and unaudited, and actual revenues may differ.

“The initial commercial launch of Sonalleve® in China, combined with growing interest from European doctors, clinics and patients in TULSA-PRO®, led to this significant rebound in quarterly revenues,” said Arun Menawat, Profound’s CEO. “We believe  this renewed sales traction should continue into 2019, and are also looking forward to a number of major milestones coming up in the first half of the year, particularly the release of the full 12-month results from the TACT pivotal study designed to further evaluate the safety and efficacy of TULSA-PRO® to ablate prostate tissue in patients with localized, organ-confined prostate cancer.”

About Profound Medical Corp.

Profound is developing the powerful combination of real-time magnetic resonance (MR) imaging and non-invasive ultrasound ablation. These key technology pillars, linked with intelligent software and robotics, have the potential to fulfill unmet needs of patients and clinicians in many anatomies and disease states, including prostate cancer, uterine fibroids, and bone metastases.

Profound is commercializing a novel technology, TULSA-PRO®, which uses real-time MR imaging to guide precise ablation of the prostate while simultaneously protecting critical surrounding anatomy. TULSA-PRO® is CE marked and is undergoing a pilot commercial launch in key European and other CE mark jurisdictions. Profound is also sponsoring a multicenter, prospective U.S. Food and Drug Administration (FDA)-registered clinical trial, TACT, which if successful, is expected to support an application to the FDA for clearance to market TULSA-PRO® in the United States.

Profound is also commercializing Sonalleve®, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. The technology was also recently approved by the Chinese Food and Drug Administration for the non-invasive treatment of uterine fibroids. The Company is in the early stages of exploring additional potential treatment markets for Sonalleve®, such as non-invasive ablation of abdominal cancers and hyperthermia for cancer therapy, where the technology has been shown to have clinical application.

Forward-Looking Statements

This release includes forward-looking statements regarding Profound and its business which may include, but is not limited to, the expectations regarding the efficacy of Profound’s technology in the treatment of prostate cancer, uterine fibroids and palliative pain treatment. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved.  Such statements are based on the current expectations of the management of Profound. The forward-looking events and circumstances discussed in this release, may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the company, including risks regarding the pharmaceutical industry, economic factors, the equity markets generally and risks associated with growth and competition. Although Profound has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Profound undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, other than as required by law.

For further information, please contact:

Stephen Kilmer
Investor Relations
skilmer@profoundmedical.com
T: 647.872.4849

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sivers Moves Q3 Release to Accommodate U.S. Investors

Updated Category News Views 0

Thanksgiving has a nasty habit of turning perfectly ordinary earnings dates into ghost towns, and Sivers Semiconductors has sensibly stepped around that pothole. The company will publish its third-quarter 2026 interim report on Monday, November 30, rather than Thursday, November 26. That is not a strategy reset, a warning, or some grand corporate mystery. It is a calendar...

Continue Reading
RBI Heads to Morgan Stanley With Plenty to Explain

Updated Category News Views 63

Two executives, one New York stage, and a short calendar gap give Restaurant Brands International a clean chance to address investors without the usual blizzard of quarterly slides. Chief Executive Officer Josh Kobza and Chief Financial Officer Sami Siddiqui are scheduled for a fireside chat at Morgan Stanley's Global Consumer & Retail Conference on December 2, 2026, at...

Continue Reading
Cybersecurity's AI Tailwind Meets a Brutal Market Test

Updated Category News Views 89

Security software caught a bid while the rest of the tape was getting kicked down the stairs. That contrast is the whole story: investors saw Palo Alto Networks deliver a strong fiscal first quarter and raise its fiscal 2027 outlook, then decided cyber defense may be one of the few technology budgets companies cannot casually postpone. With AI helping attackers locate and...

Continue Reading
Prospera’s DFW Culture Win Matters Beyond the Plaque

Updated Category News Views 46

Employee survey ballots rarely make pulses race, but this one deserves more than a lazy shrug. Prospera Financial Services has landed on The Dallas Morning News’ 2026 Top Workplaces DFW list for a second consecutive year, placing in the Top Small Workplaces category. For a boutique independent broker-dealer, that is not meaningless wall décor. The people doing the...

Continue Reading
Early Home Care Signals Families Should Not Ignore

Updated Category News Views 17

A pill organizer sitting untouched can say more than a family conversation ever will. Jay Mann of Amada Senior Care in Richmond points to a hard truth in HelloNation's Nov. 20, 2026 article: the need for in-home support often arrives quietly, disguised as little breaks in routines that everybody would rather wave away. This is not a matter for armchair diagnosis, and...

Continue Reading
Epilepsy Campaign Puts Patient Voices Before Investors

Updated Category News Views 12

An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...

Continue Reading
MFB Bancorp Offering Puts Chicago Bank Conversion First

Updated Category News Views 86

A small Chicago thrift is asking investors to fund a corporate makeover, and the fine print matters more than the $10 sticker price. MFB Bancorp has commenced an offering tied to the planned conversion of Mutual Federal Bancorp, MHC from a mutual holding company structure into a stock holding company. This is not some high-growth bank story with a shiny new branch map. It...

Continue Reading
Pennsylvania Housing Finds Its October Holding Pattern

Updated Category News Views 56

Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 21

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading
PBS Holiday Special Bets on Apollo 8, Music and Unity

Updated Category News Views 82

A moon mission, a 360-voice choir, and Christmas television make an unusual bundle, but that is precisely why this year’s Tabernacle Choir special has some real staying power. Peace on Earth: Christmas with The Tabernacle Choir is not trying to chase whatever noisy trend is chewing up attention this week. It is building a 90-minute holiday event around Apollo 8,...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Friendship and Joy: POP MART at Macy's Parade

Updated Category News Views 385

Celebration of Pop Culture at Macy's Thanksgiving Parade With excitement in the air, POP MART is gearing up for a remarkable debut at the iconic Macy's Thanksgiving Day Parade. This year marks an enchanting chapter as the brand unveils its unique float, themed "Friendsgiving in POP CITY," showcasing an array of beloved characters from the POP MART universe. The event will...

Continue Reading
NEC X Launches New Opportunity for Future Startups

Updated Category News Views 438

NEC X Invites Applications for Innovative Venture Programs NEC X, a dynamic venture studio based in Silicon Valley, is now opening its doors for applications to the Elev X! Ignite program. This initiative is geared towards transforming promising early-stage startups into fully developed businesses ready for investment. With the potential for up to $200,000 in equity...

Continue Reading
Palatin Technologies Unveils Innovative Approaches for Inflammation

Updated Category News Views 316

Palatin Technologies Unveils Innovative Approaches for Inflammation Palatin Technologies, Inc. (NYSE American: PTN), a pioneering biopharmaceutical company, has recently showcased significant advancements in the treatment of inflammatory diseases. The firm, known for its first-in-class medicines based on melanocortin receptor modulation, delivered compelling data during...

Continue Reading
Drumstick Unveils Unique Peanut Butter Sundae Cone Flavor

Updated Category News Views 623

Drumstick Launches Game-Changing Peanut Butter Sundae Cones A warm welcome to all peanut butter aficionados! Drumstick®, one of America's beloved sundae cone brands, has introduced a delightful new flavor aimed squarely at peanut butter lovers. This exciting launch brings amazing peanut butter and chocolate peanut butter sundae cones to grocery stores across the nation....

Continue Reading
Michael Saylor's Perspective on Quantum Computing and Bitcoin

Updated Category News Views 98

Michael Saylor's Vision on Quantum Computing's Impact on Bitcoin Michael Saylor, the Executive Chairman of Strategy Inc. (NASDAQ: MSTR), has made a strong claim regarding the potential influence of quantum computing on Bitcoin. On social media, he emphasized his belief that quantum computing will not undermine Bitcoin, the leading cryptocurrency, but instead enhance its...

Continue Reading